Fact CheckerSign in

NCT04730622Recruiting

Study of Parameters of Osteosarcopenia in Patients With Hip Fracture

Study of Parameters of Bone Fragility and Sarcopenia in Patients Undergoing Surgery for Fracture of the Femoral Neck

Source: ClinicalTrials.gov · Last updated 22 May 2026

Brief summary (registry, in English)

The study aims to assess the adequacy of a set of clinical and laboratory investigations for identifying the osteosarcopenia status in patients undergoing a hip replacement for a fragility fracture of the femoral neck. The control group will consist of patients undergoing a hip replacement for osteoarthritis, as the decrease in muscle function and bone quality is less severe in this condition than in osteoporosis.

Status (registry)
Recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
20 Jan 2021
Start date
23 Nov 2020
Primary completion date
31 Dec 2026
Lead sponsor
Istituto Ortopedico Rizzoli
Diseases
Osteoporosis
NCT number
NCT04730622

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 23 Nov 2020 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous osteoporotic fractures
  • Previous prosthetic surgery for orthopedic diseases
  • Chronic treatment with anti-osteoporotic drugs, immunosuppressive drugs, and insulin

Other illness

  • Pre-existing clinical conditions that led to permanent immobility
  • Neoplastic diseases
  • Autoimmune diseases
  • Chronic viral infections (HBV, HCV, HIV);
  • Paget's disease

Other

  • Severe myopathies

Who the study is looking for

  • Patients who came to observation with femoral neck fracture of possible osteoporotic nature (no or minimal trauma) to be treated with endoprosthesis or hip arthroplasty.
  • Competent patients who have signed consent to participate in the study (see Informed Consent section of this protocol).

Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istituto Ortopedico Rizzoli
Coordinator of this site? Confirm its status
BolognaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.